WO2019070220A3 - Hemostatic compositions - Google Patents

Hemostatic compositions Download PDF

Info

Publication number
WO2019070220A3
WO2019070220A3 PCT/TR2018/050541 TR2018050541W WO2019070220A3 WO 2019070220 A3 WO2019070220 A3 WO 2019070220A3 TR 2018050541 W TR2018050541 W TR 2018050541W WO 2019070220 A3 WO2019070220 A3 WO 2019070220A3
Authority
WO
WIPO (PCT)
Prior art keywords
hemostatic compositions
chitosan
granule
hemostatic
pharmaceutically acceptable
Prior art date
Application number
PCT/TR2018/050541
Other languages
French (fr)
Other versions
WO2019070220A2 (en
Inventor
Dicle Güner
Özlem KENAR
Arzu Palantöken
Ali TÜRKYILMAZ
Original Assignee
Montero Gida Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Montero Gida Sanayi Ve Ticaret Anonim Sirketi filed Critical Montero Gida Sanayi Ve Ticaret Anonim Sirketi
Publication of WO2019070220A2 publication Critical patent/WO2019070220A2/en
Publication of WO2019070220A3 publication Critical patent/WO2019070220A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a hemostatic composition comprising chitosan or pharmaceutically acceptable salts thereof and at least one mucoadhesive polymer selected from polyethylene oxide or polyethylene glycol, which is in the form of granule.
PCT/TR2018/050541 2017-10-03 2018-10-02 Hemostatic compositions WO2019070220A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2017/14879 2017-10-03
TR2017/14879A TR201714879A2 (en) 2017-10-03 2017-10-03 HEMOSTATIC COMPOSITIONS

Publications (2)

Publication Number Publication Date
WO2019070220A2 WO2019070220A2 (en) 2019-04-11
WO2019070220A3 true WO2019070220A3 (en) 2019-05-31

Family

ID=65995431

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2018/050541 WO2019070220A2 (en) 2017-10-03 2018-10-02 Hemostatic compositions

Country Status (2)

Country Link
TR (1) TR201714879A2 (en)
WO (1) WO2019070220A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120315305A1 (en) * 2010-01-08 2012-12-13 Profibrix Bv Dry Powder Fibrin Sealant
US20140105950A1 (en) * 2011-03-11 2014-04-17 Medtrade Products Limited Haemostatic material
US20170258959A1 (en) * 2013-05-30 2017-09-14 Medtrade Products Limited Degradable haemostat composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120315305A1 (en) * 2010-01-08 2012-12-13 Profibrix Bv Dry Powder Fibrin Sealant
US20140105950A1 (en) * 2011-03-11 2014-04-17 Medtrade Products Limited Haemostatic material
US20170258959A1 (en) * 2013-05-30 2017-09-14 Medtrade Products Limited Degradable haemostat composition

Also Published As

Publication number Publication date
TR201714879A2 (en) 2019-04-22
WO2019070220A2 (en) 2019-04-11

Similar Documents

Publication Publication Date Title
WO2016131067A3 (en) Pharmaceutical compositions comprising meloxicam
WO2016178586A3 (en) Collagen compositions and preparation and uses thereof
EP3681949A4 (en) Fluorinated copolymer and compositions and articles including the same
EA201390600A1 (en) THERAPEUTIC NANOPARTICLES WITH COPOLYMERS WITH A GREAT MOLECULAR WEIGHT
EP3894398A4 (en) 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same
EP3990618A4 (en) Hdac6-activated macrophages, compositions, and uses thereof
TR201713929A2 (en) Hemostatic compositions of chitosan and alginate
WO2015130602A3 (en) Sustained release composition using biobased biodegradable hyperbranched polyesters
EP3894408A4 (en) Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same
EP3556352A4 (en) Amphiphilic block copolymer composition having enhanced micelle stability, and pharmaceutical composition comprising same
EP3768675A4 (en) Novel triazolone derivatives or salts thereof and pharmaceutical compositions comprising the same
MX2018008868A (en) Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties.
WO2016137852A8 (en) Electrical tracking resistance compositions, articles formed therefrom, and methods of manufacture thereof
EP3760626A4 (en) Novel compound and composition for preventing, ameliorating, or treating fibrosis or nonalcoholic steatohepatitis comprising same as active ingredient
EP3760195A4 (en) Composition comprisng 2,3-butanediol as active ingredient
MX2022006940A (en) Pharmaceutical compositions comprising cabotegravir.
WO2016193969A3 (en) Pegylated oxyntomodulin variants
WO2020150389A3 (en) Prebiotic composition and its use
EP3539978A4 (en) Nkx3.2 fragment and pharmaceutical composition comprising same as active ingredient
WO2017075171A3 (en) Pamam dendrimer based cest imaging agents and uses thereof
WO2018017190A3 (en) Formulations of polyalkylene oxide-asparaginase and methods of making and using the same
EP4064842A4 (en) Novel protective barrier compositions, and uses thereof
WO2016137862A3 (en) Electrical tracking resistance compositions, articles formed therefrom, and methods of manufacture thereof
WO2015152577A3 (en) Composition for preventing and treating bone disease
WO2019070220A3 (en) Hemostatic compositions

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18864124

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18864124

Country of ref document: EP

Kind code of ref document: A2